AU2001264729A1 - Thromboxane inhibitors, compositions and methods of use related applications - Google Patents

Thromboxane inhibitors, compositions and methods of use related applications

Info

Publication number
AU2001264729A1
AU2001264729A1 AU2001264729A AU6472901A AU2001264729A1 AU 2001264729 A1 AU2001264729 A1 AU 2001264729A1 AU 2001264729 A AU2001264729 A AU 2001264729A AU 6472901 A AU6472901 A AU 6472901A AU 2001264729 A1 AU2001264729 A1 AU 2001264729A1
Authority
AU
Australia
Prior art keywords
compositions
methods
related applications
use related
thromboxane inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264729A
Inventor
Inigo Saenz De Tejada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitromed Inc
Original Assignee
Nitromed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitromed Inc filed Critical Nitromed Inc
Publication of AU2001264729A1 publication Critical patent/AU2001264729A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU2001264729A 2000-05-22 2001-05-22 Thromboxane inhibitors, compositions and methods of use related applications Abandoned AU2001264729A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20553600P 2000-05-22 2000-05-22
US60205536 2000-05-22
PCT/US2001/016318 WO2001089519A1 (en) 2000-05-22 2001-05-22 Thromboxane inhibitors, compositions and methods of use related applications

Publications (1)

Publication Number Publication Date
AU2001264729A1 true AU2001264729A1 (en) 2001-12-03

Family

ID=22762606

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264729A Abandoned AU2001264729A1 (en) 2000-05-22 2001-05-22 Thromboxane inhibitors, compositions and methods of use related applications

Country Status (3)

Country Link
US (1) US20030050305A1 (en)
AU (1) AU2001264729A1 (en)
WO (1) WO2001089519A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
FR2832634A1 (en) * 2001-11-29 2003-05-30 Univ Pasteur Use of L isomers of hydroxyguanidine aminoacid derivatives for treatment of vascular diseases with an inflammatory component
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
WO2004073623A2 (en) * 2003-02-14 2004-09-02 Children's Hospital & Research Center At Oakland Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
US7381537B2 (en) * 2003-05-05 2008-06-03 Probiodrug Ag Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease
CA2534316A1 (en) * 2003-08-07 2005-02-24 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxygenase-1
US20050113409A1 (en) * 2003-09-03 2005-05-26 Pharmacia Corporation Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (en) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam formulations in veterinary medicine
ATE493973T1 (en) 2004-06-04 2011-01-15 Teva Pharma PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN
DE102004030409A1 (en) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh New use of meloxicam in veterinary medicine
SE0402221D0 (en) * 2004-09-14 2004-09-14 Aerocrine Ab Treatment of insufficient perfusion
WO2006084322A1 (en) * 2005-02-09 2006-08-17 Craig Steven Mclachlan Treatment method for modifying tissue passive electrical conductance
JP2008534473A (en) * 2005-03-23 2008-08-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Composition comprising a thromboxane receptor antagonist and a thromboxane synthase inhibitor combination and a COX-2 inhibitor
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
WO2007013078A2 (en) * 2005-07-27 2007-02-01 Mor Research Applications Ltd. Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology
BRPI0617208A2 (en) * 2005-09-30 2011-07-19 Boehringer Ingelheim Vetmed pharmaceutical preparation containing meloxicam
BRPI0806686A2 (en) 2007-01-18 2014-11-04 Evolva Sa COMPOUNDS AND ITS USES, METHODS OF TREATMENT OR PREVENTION, PHARMACEUTICAL COMPOSITIONS AND CRYSTALLINE COMPOUND AND SOLVAT
ES2609825T3 (en) 2007-01-18 2017-04-24 Evolva Sa 1,3-substituted dioxanes useful as PPAR modulators
TW200916098A (en) * 2007-06-14 2009-04-16 Teijin Pharma Ltd Agent for lowering uric acid level
AR072297A1 (en) 2008-06-27 2010-08-18 Novartis Ag DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE.
EP2334279A4 (en) * 2008-10-16 2013-03-20 Novan Inc Nitric oxide releasing particles for oral care applications
BR112012003792B1 (en) 2009-08-21 2020-05-19 Novan Inc topical composition, and, use of topical composition
CN102695528B (en) 2009-08-21 2016-07-13 诺万公司 Wound dressing, its using method and forming method thereof
US9101529B2 (en) * 2009-10-12 2015-08-11 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US20110086234A1 (en) * 2009-10-13 2011-04-14 Nathan Stasko Nitric oxide-releasing coatings
WO2011057262A2 (en) * 2009-11-09 2011-05-12 Evolva Inc. Treatment of infections with tp receptor antagonists
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
CN105963293A (en) * 2016-05-30 2016-09-28 青岛云天生物技术有限公司 Pharmaceutical composition for treating myocardial infarction and application thereof
CA3082839A1 (en) * 2017-11-29 2019-06-06 Vanderbilt University Methods of inhibiting tumor metastasis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523321A (en) * 1985-07-19 1996-06-04 Schering Aktiengeselleschaft Prostacyclins, their analogs or prostaglandins and thromboxane antagonists for treatment of thrombotic and thromboembolic syndromes
GB8814726D0 (en) * 1988-06-21 1988-07-27 Glaxo Group Ltd Medicaments
US4839384A (en) * 1988-10-07 1989-06-13 E. R. Squibb & Sons, Inc. Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
FR2658511B1 (en) * 1990-02-16 1992-06-19 Union Pharma Scient Appl NOVEL BENZIMIDAZOLE AND AZABENZIMIDAZOLE DERIVATIVES, THROMBOXANE RECEPTOR ANTAGONISTS; THEIR PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5128359A (en) * 1990-02-16 1992-07-07 Laboratoires Upsa Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation
US5021448A (en) * 1990-02-22 1991-06-04 Ciba-Geigy Corporation Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
FR2685325B1 (en) * 1991-12-20 1994-02-04 Adir Cie NOVEL PYRROLIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
WO1994006785A1 (en) * 1992-09-18 1994-03-31 Toray Industries, Inc. Novel sulfonic acide derivative and medicinal use thereof
US5605917A (en) * 1994-12-22 1997-02-25 Bristol-Myers Squibb Company Method of treating dysmenorrhea employing an interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analog
AU2890899A (en) * 1998-03-13 1999-09-27 Pozen, Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists

Also Published As

Publication number Publication date
WO2001089519A1 (en) 2001-11-29
US20030050305A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
AU2001264729A1 (en) Thromboxane inhibitors, compositions and methods of use related applications
AU2001244399A1 (en) Gamma-secretase inhibitors
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2001249670A1 (en) Substituted thiazoles and the use thereof as inhibitors of plasminogen activatorinhibitor-1
AU2002229073A1 (en) Use of third party ultra wideband devices to establish geo-positional data
AU2002356762A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2002361861A1 (en) SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2001285750A1 (en) Urokinase inhibitors
AU2002327055A1 (en) Topical compositions and methods of application
AU2002367903A1 (en) Biologic-chemical herbicide compositions and methods of use
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2002303712A1 (en) Novel telomerase inhibitors and uses therefor
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2002222933A1 (en) Inhibitors of factor xa
AU2002218084A1 (en) Inhibitors of thromboxane formation and action
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2002249978A1 (en) Polymers and use thereof as scale inhibitors
AU2002306845A1 (en) Telomerase inhibitors and methods of their use